Clinical Infectious Diseases (CID) publishes practice-changing original research, reviews, guidelines, and perspectives that clinicians can use when caring for patients. CID covers the clinical presentation, diagnosis, treatment, and prevention of the full range of infectious diseases. The evaluation of current and novel treatments, microbiology, immunology, and policies as they related to patient care are highly prioritized. See CID’s full list of subject sections.

CID does not publish papers on basic mechanisms in microbiology, pathogenesis, or immunology; phase 1 clinical trials of very early-stage compounds; animal-based research not directly applicable to current clinical care; early in vitro data on treatments; or studies that focus on assays or measurements unlikely to be clinically relevant due to cost, technical challenges, or other barriers. Such studies may be a better fit for our sister journal, The Journal of Infectious Diseases.

With an Impact Factor of 11.8, the journal is ranked 10 out of 96 journals in the field of infectious diseases.

Editor-In-Chief
Robert T. Schooley, M.D. is Professor of Medicine in the Division of Infectious Diseases at the University of California, San Diego. Over the course of his career, his clinical and research interests have been in the areas of viral pathogenesis and therapy and, more recently, in the development of clinical and medical educational capacity in resource-limited settings.

Deputy Editor
Ferric C. Fang, M.D. is a Professor of Laboratory Medicine, Microbiology, Medicine, and Pathobiology at the University of Washington, where he directs the clinical microbiology laboratory at Harborview Medical Center in Seattle. Dr. Fang performs research on bacterial pathogenesis and molecular diagnostics. He comes to CID after a fifteen-year tenure as editor and editor-in-chief at the ASM journal Infection and Immunity and is responsible for the primary evaluation of CID submissions relating to bacterial, fungal and parasitic infections.

Assistant Deputy Editor
Barbara D. Alexander, M.D. is Professor of Medicine (with tenure) and Pathology, Director of Transplant Infectious Disease (ID) Services, Head of the Clinical Mycology Laboratory and Director of the Transplant ID and Medical Microbiology Fellowship Programs at Duke University. Dr. Alexander’s primary research focuses on the epidemiology, prevention, diagnosis and treatment of infections in the transplant and immunocompromised host populations. Dr. Alexander is considered a thought leader in the field of transplant ID and fungal infections.

Associate Editors
Constance A. Benson, M.D. is a Professor of Medicine and Global Public Health in the Divisions of Infectious Diseases and Global Public Health at the University of California San Diego. Her primary areas of expertise include clinical and translational research in tuberculosis and other mycobacterial infections and HIV/AIDS, particularly antiretroviral therapies and treatment and prevention of opportunistic infections.

 

Carlos del Rio, M.D. is Professor of Global Health in the Hubert Department of Global Health at the Rollins School of Public Health, Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine and co-Director of the Emory Center for AIDS Research. His interests are focused on early diagnosis, linkage and retention in care, compliance with antiretrovirals and the prevention of HIV infection among vulnerable populations both in the US and abroad.

Kathryn M. Edwards, M.D. is a Professor of Pediatrics at Vanderbilt University, Nashville, Tennessee. She has spent much of her career evaluating vaccines, facilitating their implementation, and assessing their impact. She has had an active infectious disease practice for nearly four decades and has studied periodic fever syndromes, pneumonia, and the management of complicated infections. She has also mentored many young investigators.

Vance Fowler, M.D., M.H.S. is a Professor in the Departments of Medicine and Molecular Genetics & Microbiology at Duke University Medical Center. Dr. Fowler has extensive expertise in clinical and translational research in bacterial infections. Dr. Fowler created the S. aureus Bacteremia Group and co-founded the International Collaboration on Endocarditis. He is a project PI in the Clinical Trials Transformation Initiative (CTTI) and the Communicating PI of the Antibacterial Resistance Leadership Group.

David N. Fredricks, M.D. is a Professor in the Division of Allergy and Infectious Diseases and the Department of Microbiology at the University of Washington, and a Member of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center in Seattle. He provides clinical consultation for cancer patients with infectious diseases and has an interest in bacterial and fungal infections in the immunocompromised host. His research lab studies the human indigenous microbiota and how mucosal microbial communities promote health or contribute to disease.

Barbara E. Murray, M.D. is an internationally recognized expert in infectious diseases and antibiotic resistance and one of the world’s experts on enterococci. She has been an editor of Antimicrobial Agents and Chemotherapy, program chair of ICAAC, Chair of the NIH’s Recombinant DNA Advisory Committee and has served on other NIH committees and Data Safety and Monitoring Boards, on many editorial boards, and on the FDA’s Anti-Infectives Advisory Committee. She was the Treasurer of Infectious Diseases Society of America for 6 years, Secretary for 3, President in 2013-2014 and is currently Chair of their Antimicrobial Resistance Committee.

Susanna Naggie, M.D., M.H.S. is Associate Professor of Medicine (with tenure) and Associate Dean of Clinical Research Initiatives and Regulatory Affairs at Duke University School of Medicine. Dr. Naggie’s primary research focuses on discoveries to individualize care for people with HIV and viral hepatitis including pharmacogenomics, metabolomics and proteomics investigations. She is also engaged in clinical trial design and coordination at the Duke Clinical Research Institute.

Peter G. Pappas, M.D. is a widely recognized expert in the epidemiology, diagnosis, and treatment of invasive mycoses. He is a Professor of Internal Medicine and Infectious Diseases at the University of Alabama at Birmingham where he directs the Antimicrobial Stewardship Program for the University of Alabama Health System. He is also currently Principle Investigator of the Mycoses Study Group Education and Research Consortium (MSGERC), a multi-center, international clinical trials and education group.

Robin Patel, M.D. is currently Professor of Medicine, Professor of Microbiology, Chair of the Division of Clinical Microbiology, and Director of the Infectious Diseases Research Laboratory at Mayo Clinic. Dr. Patel is a Fellow of American Academy of Microbiology, co-chair of the ASM Microbe 2016 and 2017 Program Planning Committee, an associate editor for the Journal of Clinical Microbiology, and course director for the Mayo Medical School Microbiology course. Her research focuses on clinical bacteriology diagnostic testing, antimicrobial resistance, and microbial biofilms.

David L. Paterson, M.D., Ph.D. is an Infectious Disease Physician in Brisbane, Australia. He is CEO of Wesley Medical Research with an affiliation to the University of Queensland. Prior to returning to Australia, he worked for 10 years at the University of Pittsburgh Medical Center. His research interests are in antibiotic resistance, particularly of Gram-negative bacilli. He has more than 380 peer-reviewed publications, including more than 50 in Clinical Infectious Diseases.

 

David A. Pegues, M.D. is Professor of Medicine in the Division of Infectious Diseases at the Perelman School of Medicine at the University of Pennsylvania, Medical Director of Healthcare Epidemiology, Infection Prevention and Control and Co-Director of the Antimicrobial Stewardship Program at the Hospital of the University of Pennsylvania. His interests include device-associated infections; novel infection control technologies to reduce microbial contamination of the environment, and antimicrobial stewardship interventions to improve clinical outcomes.

William A. Petri, Jr., M.D., Ph.D. is Chief of the Division of Infectious Diseases & International Health at the University of Virginia. Petri studies the pathogenesis of amebiasis and C. difficile colitis in murine models, and in Bangladesh conducts longitudinal studies of enteric infections in infants and resulting gut barrier dysfunction, oral vaccine failure, malnutrition, and child developmental disability.

 

Stephanie N. TaylorStephanie N. Taylor, M.D. is a Professor of Medicine and Microbiology in the Infectious Diseases Section of Louisiana State University Health Sciences Center and is board-certified in both Internal Medicine and Infectious Diseases. Dr. Taylor’s expertise is sexually transmitted infections and STI diagnostic and clinical trials. She is currently medical director of the LSU Infectious Diseases STI Program and laboratory, the LSU Sexual Health Clinic and the LA Office of Public Health STD/HIV Program.

Cover Art Editors
Mary Grizzard

Michael Grizzard

Statistical Associate Editor
Victor De Gruttola

Statistical Editors
Norma Terrin, Senior Editor

Steven Cohen

Farzad Noubary

Histopathology Editors
Jeannette Guarner

Mary Klassen-Fischer

Editorial Office Staff
Carlos M. Terra, Managing Editor

Blake Campbell, Editorial Office Assistant

CID.EditorialOffice@oup.com

Special Section Editors     
Book Reviews
Gary P. Wormser

Clinical Practice
Ellie J. C. Goldstein

Healthcare Epidemiology
Robert A. Weinstein

Immunocompromised Hosts
David R. Snydman

Innovations in Design, Education and Analytics (IDEA)
Victor De Gruttola

Scott R. Evans

In the Literature
Stan Deresinski

News
Donald Kaye

Photo Quiz/Arcanum
Anthony Amoroso

Reviews of Anti-infective Agents
Louis D. Saravolatz

Vaccines
Stanley Plotkin

Past Editors
Reviews of Infectious Diseases
Edward H. Kass, 1979-1989 (vols. 1-11)

Sydney M. Finegold, 1990-1991 (vols. 12 and 13)

Clinical Infectious Diseases
Sydney M. Finegold, 1992-1999 (vols. 14-29)

Sherwood L. Gorbach, 2000–2016 (vols. 30–63)

Editorial Advisory Board
Anucha Apisarnthanarak, Pratumthani, Thailand

Roberto Badaro, Salvador, Brazil

Carol J. Baker, Houston

Fernando Baquero, Madrid, Spain

John G. Bartlett, Baltimore

Stephen G. Baum, New York

John E. Bennett, Bethesda

Emilio Bouza, Madrid, Spain

Yehuda Carmeli, Tel Aviv, Israel

G. Ralph Corey, Durham

Erika M.C. D'Agata, Boston

Silvano Esposito, Naples, Italy

Javier Garau, Barcelona, Spain

Jose M. Gatell, Barcelona, Spain

M. Lindsay Grayson, Melbourne, Australia

James G. Hakim, Harare, Zimbabwe

Carol A. Kauffman, Ann Arbor

Keith P. Klugman, Atlanta

Umesh G. Lalloo, Congella, South Africa

Stephen D. Lawn, Cape Town, South Africa

Catherine Leport, Paris, France

Daniel P. Lew, Geneva, Switzerland

Lionel A. Mandell, Hamilton, Canada

Jeanne M. Marrazzo, Seattle

Thomas J. Marrie, Halifax, Canada

Daniel M. Musher, Houston

Carl Erik Nord, Stockholm, Sweden

Timothy Peto, Oxford, England

Didier Raoult, Marseille, France

Guillermo M. Ruiz-Palacios, Tlalpan, Mexico

Marisela Silva, Caracas, Venezuela

Vincent Soriano, Madrid, Spain

Soumya Swaminathan, Chennai, India

Joseph M. Vinetz, La Jolla

Gui-Qiang Wang, Beijing, China

Andreas F. Widmer, Basel, Switzerland

Kwok-yung Yuen, Hong Kong, China

Anita K. M. Zaidi, Karachi, Pakistan

Abigail D. Zuger, New York